Lv1
40 积分 2023-12-06 加入
Hemorrhagic and ischemic risks of anti-VEGF therapies in glioblastoma
2天前
已完结
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
2个月前
已完结
Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL
2个月前
已完结
[Investigation of luminescence mechanism of hybrid MEH-PPV/ SiO2 and super liner characteristic of amorphous SiO2]
2个月前
已关闭
Cytokine release syndrome and relevant factors of CD19 targeted chimeric antigen receptor T cell therapy in relapsed/refractory B cell hematological malignancies
3个月前
已完结
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
3个月前
已完结
Systematic Review and Meta-analysis of CD19-Specific CAR-T Cell Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia in the Pediatric and Young Adult Population: Safety and Efficacy Outcomes
3个月前
已完结
皖公网安备34019202002308
